![Blai Coll](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Blai Coll
Teknisk/Vetenskaplig/F&U Direktör på
STRUCTURE THERAPEUTICS INC.
Förmögenhet: 4 M $ per 2026-08-31
Profil
Dr. Blai Coll is a Chief Medical Officer at Structure Therapeutics, Inc. Dr. Coll was previously employed as a Medical Director by AbbVie, Inc. He received his doctorate degree from Autonomous University of Barcelona and a doctorate degree from Universitat Rovira i Virgili.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-09-21 | 258 228 ( 0,18 % ) | 4 M $ | 2026-08-31 |
Aktiva positioner av Blai Coll
| Företag | Position | Start |
|---|---|---|
| STRUCTURE THERAPEUTICS INC. | Teknisk/Vetenskaplig/F&U Direktör | 2024-09-18 |
Tidigare kända positioner av Blai Coll
| Företag | Position | Slut |
|---|---|---|
| ABBVIE INC. | Teknisk/Vetenskaplig/F&U Direktör | - |
Blai Colls utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
19
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Autonomous University of Barcelona
 Autonomous University of Barcelona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universitat Rovira i Virgili
 Universitat Rovira i Virgili Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Structure Therapeutics, Inc.
 Structure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops molecule therapeutics to treat chronic diseases | Health Technology |
